Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
David Malka(Université Paris-Sud), Pascale Cervera(Sorbonne Université), Stéphanie Foulon(Université Paris-Sud), Tanja Trarbach, Christelle de la Fouchardière(Centre Léon Bérard), Éveline Boucher(Centre Eugène Marquis), Lætitia Fartoux(Hôpital Saint-Antoine), Sandrine Faivre(Hôpital Beaujon), Jean‐Frédéric Blanc(Hôpital Saint-André), F. Viret(Institut Paoli-Calmettes), Eric Assénat(CEA Valduc), Thomas Seufferlein(Universität Ulm), Thomas Herrmann(Heidelberg University), Julien Grenier(Hôpitaux Universitaires Henri-Mondor), Pascal Hammel(Hôpital Beaujon), Matthias Dollinger(University Hospital in Halle), Thierry André(Pitié-Salpêtrière Hospital), Philipp Hahn(University Hospital Regensburg), Volker Heinemann(Ludwig-Maximilians-Universität München), Vanessa Rousseau(Institut Gustave Roussy), Michel Ducreux(Institut Gustave Roussy), Jean‐Pierre Pignon(Institut Gustave Roussy), Dominique Wendum(Sorbonne Université), Olivier Rosmorduc(Hôpital Saint-Antoine), Tim F. Greten(Medizinische Hochschule Hannover)
Cited by 413Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis